Non-US Residents | Contact Us | Site Map | Large-Text VersionRegular Text Version

Welcome to Novartis Oncology US - This site is intended for US Residents only

 

 

 

Commitment to Patients

About Us

Commitment to Patients

Public Affairs & Communications provides support to patients through:

  • Access to medications
  • Advocacy
  • Communication
  • Health care policy efforts

Patient Advocacy includes several areas of therapeutic interest, including, but not limited to:

  • Acute Myeloid Leukemia
  • Acromegaly
  • Bone Health
  • Breast Cancer
  • Clinical Trial Awareness and Education
  • Chronic Myeloid Leukemia
  • Cushing’s Disease
  • Gastrointestinal Stromal Tumors
  • Iron Overload (transfusional)
  • Sickle Cell Anemia
  • Thalassemia
  • Myelodysplastic Syndromes
  • Lymphomas
  • Multiple Myeloma
  • Neuroendocrine Tumor
    • Carcinoid Syndrome
    • Pancreatic Islet Cell Cancer
  • Renal Cell Cancer
  • Tuberous Sclerosis Complex

Some Types of Programs Supported by Patient Advocacy

  • Patient Education/Disease Awareness
  • Clinical Trial Awareness
  • Psychosocial Support
  • Community Outreach
Learn more about patient advocacy grant and sponsorship support

 

OPM Newsletter

news Education

OPM Newsletters provide updates on the latest topics in health care reform, policy, reimbursement, and information for practice managers.

PATIENT ASSISTANCE NOW ONCOLOGY

Quick and easy access to Novartis Oncology reimbursement and support programs.

RESEARCH AND DEVELOPMENT

Our research and development is crucial to providing you with innovative treatments.